Edition:
United States

North China Pharmaceutical Co Ltd (600812.SS)

600812.SS on Shanghai Stock Exchange

4.37CNY
23 Feb 2018
Change (% chg)

¥0.02 (+0.46%)
Prev Close
¥4.35
Open
¥4.38
Day's High
¥4.45
Day's Low
¥4.35
Volume
2,785,100
Avg. Vol
3,208,271
52-wk High
¥7.60
52-wk Low
¥4.11

Select another date:

Mon, Feb 12 2018

BRIEF-North China Pharmaceutical receives GMP certificate

* Says it received goods manufacture practice (GMP) certificate from Hebei Food and Drug Administration

BRIEF-North China Pharmaceutical receives GMP certificate

* Says it received goods manufacture practice (GMP) certificate from Hebei Food and Drug Administration on Feb. 6

BRIEF-North China Pharmaceutical sees FY 2017 net profit down 50 pct to 70 pct

* Sees FY 2017 net profit to decrease by 50 percent to 70 percent, or to decreased by 27 million yuan to 38 million yuan

BRIEF-North China Pharmaceutical to issue up to 2 bln yuan commercial paper

* Says it plans to issue up to 2.0 billion yuan ($302.20 million) commercial paper

BRIEF-North China Pharmaceutical issues 2017 second tranche corporate bonds worth 290 mln yuan

* Says it issued 2017 second tranche corporate bonds worth 290 million yuan

BRIEF-North China Pharmaceutical sets coupon rate of 2017 2st tranche corporate bonds at 6.2 pct

* Says it sets coupon rate of 2017 2st tranche corporate bonds at 6.2 percent

BRIEF-North China Pharmaceutical to issue 290 mln yuan 4-year bonds

* Says to issue 290 million yuan ($43.97 million) 4-year bonds

Select another date: